Jiangsu Hengrui Pharmaceuticals Co., Ltd. Insider Trading

Name: Jiangsu Hengrui Pharmaceuticals Co., Ltd. insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Aug 10, 2026): Conversion of 7,420,091 BRVE shares.

Get alerted when insiders trade BRVE

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Latest filings by Jiangsu Hengrui Pharmaceuticals Co., Ltd.

Filed	Company	Transaction	Shares	Value
Aug 10, 2026	Braveheart Bio, Inc. (BRVE)	Conversion	7,420,091	n/a
Apr 22, 2026	Kailera Therapeutics, Inc. (KLRA)	Conversion	9,477,719	n/a

Loading insider data...